Skip to main content
. Author manuscript; available in PMC: 2022 Feb 16.
Published in final edited form as: Clin Trials. 2021 Nov 29;19(1):86–96. doi: 10.1177/17407745211046672

Table 5.

Methods of analysis and reporting of correlation coefficients (N=62)

Characteristic Frequency (%)

Did primary analysis of primary outcome account for clustering?
Cluster randomized trials (N=38)
 Yes: Analysis was at individual-level accounting for clustering 20 (52.6%)
 Yes: Analysis was at cluster-level 3 (7.9%)
 Yes: Othera 2 (5.3%)
 No: Analysis was at individual-level not accounting for clustering 11 (28.9%)
 No: Clustering effect was small; proceeded without accounting for clustering 1 (2.6%)
 Unclear whether accounted for clustering 1 (2.6%)
Individually randomized group treatment trial (N=9)
 Yes: Analysis was at individual-level accounting for clustering 1 (11.1%)
 No: Analysis was at individual-level not accounting for clustering 7 (77.8%)
 No: Clustering effect was small; proceeded without accounting for clustering 1 (11.1%)

Were repeated measures utilized in primary analysis of the primary outcome? (N=54)
 Yes 35 (64.8%)
 No 19 (35.2%)

Was correlation in dyadic or multivariate outcome accounted for in analysis? (N=17)
 Yes 1 (5.9%)
 No 16 (94.1%)

Reported any correlation coefficients?
 Trials with potential intracluster correlation (N=47) 17 (36.2%)
 Trials with potential correlation over time (N=54) 0
 Trials with potential correlation between multivariate outcomes (N=17) 0

Methods of analysis
 Simple method (e.g., t-test, chi-squared test) 9 (14.5%)
 Generalized Estimating Equations (GEE) 11 (17.7%)
 Mixed-effects regression 22 (35.5%)
 Fixed-effects regression 16 (25.8%)
 Other (e.g., structural equation modeling, MANCOVA, two-stage method) 4 (6.5%)
a

One trial conducted analyses at both individual-level accounting for clustering and cluster-level; one trial used a two-stage method: in stage one ANCOVA was used within each cluster-pair; in stage two random effects meta-analysis was used